Morning Breakouts

Latest KFF Health News Stories

Pharma Companies Have Infiltrated Process That Determines How Their Drugs Are Covered By Taxpayers

Morning Briefing

An investigation by NPR and the Center for Public Integrity looks at the brazen and sometimes illegal steps the companies take to get their medication on Medicaid’s “preferred drug lists.” In other pharmaceutical news: FDA Chief Scott Gottlieb blasts drugmakers for blocking development of biosimilars; the White House is reviewing a plan to curb drug rebates; a Senate panel will vote on “gag clauses” next week; and more.

Novartis Becomes Second Pharma Company To Pull Back On 2018 Price Increases

Morning Briefing

Recently, Pfizer was lambasted by President Donald Trump over its price hikes and announced it would roll them back. Novartis, which is dealing with a public relations crisis from its contact with Trump’s personal attorney Michael Cohen, said it is following suit: “We thought that was prudent, given the dynamic environment we’re currently in,” said Chief Executive Vas Narasimhan.

U.S. Returning To Pre-ACA Days Where How Much You Pay For Insurance Is All About Location, Location, Location

Morning Briefing

States are taking on more power as the Trump administration and Republicans chip away at federal regulations, leaving the landscape bumpy and uneven. Meanwhile, the National Federation of Independent Business, after lobbying for years, said it won’t set up an association health plan because the new rules laid out by President Donald Trump are unworkable.